METAVIR | Genre | Populations (%) | Ethylism | Comorbidities | V.L. (log10)a | ALTa | AST* | GGTa | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
M | F | PHCC | PHBC | No | Yes | No | Yes | |||||
Degree of hepatic inflammation | ||||||||||||
A0-A1 | 43 | 26 | 40 (58.82) | 29 (82.86) | 36 (72.00) | 33 (66.00) | 33 (78.57) | 36 (59.02) | 5.63 ± 0.74 | 62.52 ± 60.48 | 62.52 ± 60.48 | 63.19 ± 74.28 |
A2-A3 | 19 | 15 | 28 (41.18) | 06 (17.14) | 14 (28.00) | 17 (34.00) | 9 (21.43) | 25 (40.98) | 5.21 ± 1.15 | 106.93 ± 74.84 | 90.23 ± 71.84 | 89.33 ± 60.93 |
Degree of liver fibrosis | ||||||||||||
F0-F1 | 29 | 20 | 27 (39.71) | 22 (62.86) | 26 (52.00) | 23 (46.00) | 29 (69.05) | 20 (32.79) | 5.31 ± 1.00 | 72.53 ± 71.50 | 55.62 ± 40.16 | 66.68 ± 74.94 |
F2 | 16 | 10 | 17 (25.00) | 09 (25.71) | 13 (26.00) | 14 (28.00) | 4 (09.52) | 23 (37.70) | 5.63 ± 0.64 | 74.88 ± 63.10 | 62.77 ± 47.64 | 62.79 ± 47.43 |
F3-F4 | 17 | 11 | 24 (35.29) | 04 (11.43) | 11 (22.00) | 13 (26.00) | 9 (21.43) | 18 (29.51) | 5.43 ± 1.14 | 87.96 ± 69.11 | 82.87 ± 74.6 | 91.90 ± 80.45 |
Total | 62 | 41 | 68 | 35 | 50 | 50 | 42 | 61 | 5.45 ± 0.96 | 76.86 ± 68.33 | 64.00 ± 52.69 | 72.19 ± 70.75 |